BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8001513)

  • 1. Use of saliva in home monitoring of carbamazepine levels.
    Rosenthal E; Hoffer E; Ben-Aryeh H; Badarni S; Benderly A; Hemli Y
    Epilepsia; 1995 Jan; 36(1):72-4. PubMed ID: 8001513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
    Vasudev A; Tripathi KD; Puri V
    Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple collection method for saliva in children: potential for home monitoring of carbamazepine therapy.
    Chee KY; Lee D; Byron D; Naidoo D; Bye A
    Br J Clin Pharmacol; 1993 Mar; 35(3):311-3. PubMed ID: 8471410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of saliva samples in monitoring carbamazepine concentrations in epileptic patients.
    Kristensen O; Larsen HF
    Acta Neurol Scand; 1980 Jun; 61(6):344-50. PubMed ID: 6998249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of saliva in monitoring carbamazepine medication in epileptic children.
    Bartels H; Oldigs HD; Günther E
    Eur J Pediatr; 1977 Aug; 126(1-2):37-44. PubMed ID: 902662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Saliva and plasma levels of carbamazepine have a poor correlation: a pilot study].
    Mennickent S; Vega M; Godoy CG; León MD
    Rev Med Chil; 2007 Mar; 135(3):335-40. PubMed ID: 17505579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine determination in saliva of children: enzyme immunoassay (EMIT) versus high pressure liquid chromatography.
    Paxton JW
    Epilepsia; 1982 Apr; 23(2):185-9. PubMed ID: 7042328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children.
    Paxton JW; Aman MG; Werry JS
    Epilepsia; 1983 Dec; 24(6):716-24. PubMed ID: 6641647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
    Miles MV; Tang PH; Ryan MA; Grim SA; Fakhoury TA; Strawsburg RH; DeGrauw TJ; Baumann RJ
    Ther Drug Monit; 2004 Jun; 26(3):300-4. PubMed ID: 15167632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva.
    Dwivedi R; Singh M; Kaleekal T; Gupta YK; Tripathi M
    Int J Neurosci; 2016 Nov; 126(11):972-8. PubMed ID: 26441313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary and serum concentrations, and protein binding of carbamazepine in young epileptic patients.
    Paxton JW
    Methods Find Exp Clin Pharmacol; 1983; 5(6):397-401. PubMed ID: 6621183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous liquid chromatographic analysis for carbamazepine and carbamazepine 10,11-epoxide in plasma and saliva by use of double internal standardization.
    MacKichan JJ
    J Chromatogr; 1980 Mar; 181(3-4):373-83. PubMed ID: 7391153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of phenytoin and carbamazepine in an ultrafiltrate of saliva.
    Schramm W; Annesley TM; Siegel GJ; Sackellares JC; Smith RH
    Ther Drug Monit; 1991 Sep; 13(5):452-60. PubMed ID: 1957339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary anticonvulsant levels in children with epilepsy.
    Day RE; Chambers RE
    Br J Clin Pract; 1981 Jan; 35(1):25-9. PubMed ID: 7259942
    [No Abstract]   [Full Text] [Related]  

  • 15. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
    MacKichan JJ; Duffner PK; Cohen ME
    Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and acceptance of salivary monitoring of antiepileptic drugs via the US Postal Service.
    Tennison M; Ali I; Miles MV; D'Cruz O; Vaughn B; Greenwood R
    Ther Drug Monit; 2004 Jun; 26(3):295-9. PubMed ID: 15167631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.
    Chbili C; Hassine A; Ben Amor S; Nouira M; Ben Ammou S; Saguem S
    Rev Neurol (Paris); 2016; 172(4-5):313-7. PubMed ID: 27062293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine and lamotrigine plasma concentrations in epileptic patients during optimising therapy.
    Krasniqi S; Neziri B; Islami H; Bauer S
    Med Arh; 2010; 64(2):80-3. PubMed ID: 20514770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
    Rane A; Höjer B; Wilson JT
    Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.